Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Medical Condition: Non Small Cell Lung Cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non+Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non+Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non+Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (318)
1
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC : Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of ALectinib as NEO-adjuvant Therapy in Patients With Anaplastic Lymphoma Kinase-positive (ALK+) Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC): ALNEO Trial
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD : Dynamic Observational Strategy for Stage IB-IIIA Non-Small Cell Lung Cancer Patients After Complete Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) : DZD9008 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutations: Cohort Study
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit : Non-interventional Biomarker Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit, From Patients With Non-Small Cell Lung Cancer, Screened in Clinical Study (Protocol No. 20190294).
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Pharmacokinetic Boosting of Osimertinib : Pharmacokinetic Boosting of Osimertinib in Patients With Non-small Cell Lung Cancer.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) : Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Radically Resected Non Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC : Phase II Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib and Adjuvant Pembrolizumab in Patients With Surgically Resectable Non-Small- Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations : Phase I Study of Osimertinib+Bevacizumab+Carboplatin and Pemetrexed for Untreated Patients With EGFR Mutation Advanced Non-squamous Non-Small Cell Lung Cancer With Concomitant Mutations.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer : A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer : Phase II Study Evaluating the Combination of Cetuximab With Afatinib as First-line Treatment for Patients With EGFR Mutated Non Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Medical Condition: Non Small Cell Lung Cancer
Medienart
318
Aufsätze
318
E-Artikel
318
E-Ressourcen
Zeitschriftentitel
318
ClinicalTrials.gov
Thema
318
610
Carcinoma, Non-Small-Cell Lung
Medical Condition: Non Small Cell Lung Cancer
262
Lung Neoplasms
249
Study Type: Interventional
160
Recruitment Status: Completed
136
Phase: Phase 2
62
Study Type: Observational
48
Recruitment Status: Unknown status
38
Recruitment Status: Recruiting
34
Recruitment Status: Terminated
33
Phase: Phase 1
24
Phase: Phase 3
17
Recruitment Status: Not yet recruiting
13
Phase: Phase 1/Phase 2
13
Recruitment Status: Withdrawn
7
Study Type: Observational [Patient Registry]
4
Phase: Early Phase 1
4
Phase: Phase 4
3
Recruitment Status: Active, not recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
107
2020-
195
2010-2019
16
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
318
Englisch
Haven't found what you're looking for?
Wird geladen...